Draganfly is a 20+ Year Old Technology Developer Specializing In Drones, Sensors and AI

Clients’ Include: Government of Canada, Ontario Provincial Police, Australian Federal Police, Royal Canadian Mounted Police, Illinois State Police, Shell and Dow

Sponsored
AGORACOM NEWS FLASH

NEW LISTING ALERT!!!

Awakn Life Sciences to Commence Trading on the NEO Exchange Under the Symbol 'AWKN'

  • Strategic focus on developing and delivering psychedelic medicines to treat Addiction.
  • Strong psychedelic drug development pipeline targeting Addiction.
  • First mover advantage for clinics in the UK and the EU with 400m people and CAD$25TR GDP.
  • The leading research and clinical team in the industry focused on using psychedelics to treat Addiction.
  • Multiple scalable revenue streams across drug development and clinical delivery.

Awakn logoset 300x100

Hub On AGORACOM / Corporate Profile / Recent Interview

 

 

Message: Draganfly Selected by Knightscope to Integrate Mobile Vital Sign Screening Technology into its Autonomous Security Robots

Draganfly Selected by Knightscope to Integrate Mobile Vital Sign Screening Technology into its Autonomous Security Robots

posted on Jan 12, 2021 09:00AM

Initial Five Orders Integrated and Delivered

Los Angeles, CA., Jan. 12, 2021 -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that Knightscope, Inc. (“Knightscope”) has selected to implement Draganfly’s Vital Intelligence technology into its autonomous security robots and embedded applications.

Founded in Silicon Valley, Knightscope is a leader in developing autonomous security capabilities with a vision to one day be able to predict and prevent crime disrupting the $500 billion security industry. The technology is a profound combination of self-driving technology, robotics and artificial intelligence.

The technology implemented by Draganfly can measure key vital signs. The system uses an advanced microcontroller to perform sophisticated image processing in real time, while consuming less than 50W of electrical power. Despite its small size and power consumption, this fully featured system has a web-based API that works seamlessly with Knightscope’s in autonomous operating platform.

The system is made in the USA adhering to required security protocols and follows FDA approved processes.

“This technology will enable real-time vital sign screening which has become a critical component in providing our clients with a comprehensive public safety solution’” said William Santana Li, Chairman and CEO of Knightscope. “We chose Draganfly’s because of their commitment to providing the best, most secure and accurate vital signs screening available.”

“We are incredibly excited to be partnering with Knightscope to deliver our Vital Intelligence technology within their autonomous security robots,” said Cameron Chell, CEO of Draganfly. “The combination of our technologies is a solution that provides a new level of public safety and security.”

About Knightscope

Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. Our long-term ambition is to make the United States of America the safest country in the world. Learn more about us at www.knightscope.com .

About Draganfly

Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge and software and systems that revolutionize the way organization can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

For more information on Draganfly, please visit us at www.draganfly.com . For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc , https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.

Media Contact Arian Hopkins email: [email protected]

Company Contact Email: [email protected]

Forward-Looking Statements

This release contains certain “forward looking statements” and certain “forward-looking ‎‎‎‎information” as ‎defined under applicable Canadian securities laws. Forward-looking statements ‎‎‎‎and information can ‎generally be identified by the use of forward-looking terminology such as ‎‎‎‎‎“may”, “will”, “expect”, “intend”, ‎‎“estimate”, “anticipate”, “believe”, “continue”, “plans” or similar ‎‎‎‎terminology. Forward-looking statements ‎and information are based on forecasts of future ‎‎‎‎results, estimates of amounts not yet determinable and ‎assumptions that, while believed by ‎‎‎‎management to be reasonable, are inherently subject to significant ‎business, economic and ‎‎‎‎competitive uncertainties and contingencies. Forward-looking statements ‎include, but are not ‎‎‎‎limited to, statements with respect to the successful utilization and integration of the ‎Company’s Vital ‎‎‎‎Intelligence technology. ‎Forward-‎‎‎‎looking statements and information are subject to various known and unknown risks and ‎‎‎‎‎uncertainties, many of which are beyond the ability of the Company to control or predict, that ‎‎‎‎may cause ‎the Company’s actual results, performance or achievements to be materially different ‎‎‎‎from those ‎expressed or implied thereby, and are developed based on assumptions about such ‎‎‎‎risks, uncertainties ‎and other factors set out here in, including but not limited to: the potential ‎‎‎‎impact of epidemics, ‎pandemics or other public health crises, including the current outbreak of ‎‎‎‎the novel coronavirus known as ‎COVID-19 on the Company’s business, operations and financial ‎‎‎‎condition, the successful integration of ‎technology, the inherent risks involved in the general ‎‎‎‎securities markets; uncertainties relating to the ‎availability and costs of financing needed in the ‎‎‎‎future; the inherent uncertainty of cost estimates and the ‎potential for unexpected costs and ‎‎‎‎expenses, currency fluctuations; regulatory restrictions, liability, ‎competition, loss of key ‎‎‎‎employees and other related risks and uncertainties disclosed under the ‎heading “Risk Factors“ ‎‎‎‎in the Company’s most recent filings filed with securities regulators in Canada on ‎the SEDAR ‎‎‎‎website at www.sedar.com. The Company undertakes no obligation to update forward-‎looking ‎‎‎‎information except as required by applicable law. Such forward-looking information represents ‎‎‎‎‎managements’ best judgment based on information currently available. No forward-looking ‎‎‎‎statement ‎can be guaranteed and actual future results may vary materially. Accordingly, readers ‎‎‎‎are advised not to ‎place undue reliance on forward-looking statements or information‎.

Share
New Message
Please login to post a reply